Background: Retrospective studies have drawn attention to possible detrimental effects of non-steroidal anti-inflammatory drugs (NSAIDs) on the anastomotic leakage rate after colorectal resection. In this study, we examined the effects of the NSAID diclofenac on the breaking strength of an experimental colonic anastomosis and a skin incision as well as subcutaneous collagen accumulation. Methods: This was a randomized, blinded, placebo-controlled experimental study in 60 male Wistar rats treated with diclofenac 4 mg/kg/day or placebo. In each rat, a colonic anastomosis was performed and an expanded polytetrafluoroethylene (ePTFE) tube was placed subcutaneously. Incisional and anastomotic wound breaking strength and hydroxyproline content in the ePTFE tubes were measured 7 days after the operation. Results: We found no significant differences in any of the breaking strength measurements, but showed a median 38% reduction in hydroxyproline deposition as a result of diclofenac treatment (p = 0.03). In the placebo group, subcutaneous collagen deposition tended to correlate positively with skin incisional but negatively with anastomotic bio-mechanical strength. Conclusion: Postoperative diclofenac treatment significantly inhibited collagen deposition in subcutaneous granulation tissue. Anastomotic strength and skin wound strength were not significantly affected. The ePTFE model is suitable for assessing the effect of various drugs on collagen formation and thus on wound healing.

Keywords:
Colonic anastomosis, Expanded polytetrafluoroethylene, Anastomotic leakage, Diclofenac, Hydroxyproline, Collagen, Wound healing, Breaking strength
1.
Kehlet H, Wilmore DW: Evidence-based surgical care and the evolution of fast-track surgery. Ann Surg 2008;248:189-198.
2.
Krotz F, Struthmann L: A Review on the risk of myocardial infarction associated with the NSAID diclofenac. Cardiovasc Hematol Disord Drug Targets 2010;10:53-65.
3.
McGettigan P, Henry D: Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. JAMA 2006;296:1633-1644.
4.
Nussmeier NA, Whelton AA, Brown MT, Langford RM, Hoeft A, Parlow JL, Boyce SW, Verburg KM: Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery. N Engl J Med 2005;352:1081-1091.
5.
Holte K, Andersen J, Jakobsen DH, Kehlet H: Cyclo-oxygenase 2 inhibitors and the risk of anastomotic leakage after fast-track colonic surgery. Br J Surg 2009;96:650-654.
6.
Klein M, Andersen LP, Harvald T, Rosenberg J, Gögenur I: Increased risk of anastomotic leakage with diclofenac treatment after laparoscopic colorectal surgery. Dig Surg 2009;26:27-30.
7.
Rosenberg J, Harvald T: Severe complications with diclofenac after colonic resection. Dis Colon Rectum 2007;50:685.
8.
Cahill RA, Sheehan KM, Scanlon RW, Murray FE, Kay EW, Redmond HP: Effects of a selective cyclo-oxygenase 2 inhibitor on colonic anastomotic and skin wound integrity. Br J Surg 2004;91:1613-1618.
9.
De Hingh IH, van Goor H, de Man BM, Lomme RM, Bleichrodt RP, Hendriks T: Selective cyclo-oxygenase 2 inhibition affects ileal but not colonic anastomotic healing in the early postoperative period. Br J Surg 2006;93:489-497.
10.
De Sousa JB, Soares EG, Aprilli F: Effects of diclofenac sodium on intestinal anastomotic healing. Experimental study on the small intestine of rabbits. Dis Colon Rectum 1991;34:613-617.
11.
Inan A, Koca C, Sen M: Effects of diclofenac sodium on bursting pressures of anastomoses and hydroxyproline contents of perianastomotic tissues in a laboratory study. Int J Surg 2006;4:222-227.
12.
Mastboom WJ, Hendriks T, van Elteren P, de Boer HH: The influence of NSAIDs on experimental intestinal anastomoses. Dis Colon Rectum 1991;34:236-243.
13.
Neuss H, Raue W, Muller V, Weichert W, Schwenk W, Mall JW: Effects of cyclooxygenase inhibition on anastomotic healing following large bowel resection in a rabbit model - a randomized, blinded, placebo-controlled trial. Int J Colorectal Dis 2009;24:551-557.
14.
Klein M, Krarup PM, Burcharth J, Ågren MS, Gögenur I, Jorgensen LN, Rosenberg J: Effect of diclofenac on cyclooxygenase-2 levels and early breaking strength of experimental colonic anastomoses and skin incisions. Eur Surg Res 2010;46:26-31.
15.
Agren MS, Andersen L, Heegaard AM, Jorgensen LN: Effect of parenteral zinc sulfate on colon anastomosis repair in the rat. Int J Colorectal Dis 2008;23:857-861.
16.
Danielsen CC, Andreassen TT: Mechanical properties of rat tail tendon in relation to proximal-distal sampling position and age. J Biomech 1988;21:207-212.
17.
Da Costa MA, Campos AC, Coelho JC, de Barros AM, Matsumoto HM: Oral glutamine and the healing of colonic anastomoses in rats. JPEN J Parenter Enteral Nutr 2003;27:182-185.
18.
Koruda MJ, Rolandelli RH: Experimental studies on the healing of colonic anastomoses. J Surg Res 1990;48:504-515.
19.
Jorgensen LN: Collagen deposition in the subcutaneous tissue during wound healing in humans: a model evaluation. APMIS Suppl 2003;115:1-56.
20.
Wicke C, Halliday BJ, Scheuenstuhl H, Foree EF, Hunt TK: Examination of expanded polytetrafluoroethylene wound healing models. Wound Repair Regen 1995;3:284-291.
21.
Ekmektzoglou KA, Zografos GC, Kourkoulis SK, Dontas IA, Giannopoulos PK, Marinou KA, Poulakou MV, Perrea DN: Mechanical behavior of colonic anastomosis in experimental settings as a measure of wound repair and tissue integrity. World J Gastroenterol 2006;12:5668-5673.
22.
Ikeuchi D, Onodera H, Aung T, Kan S, Kawamoto K, Imamura M, Maetani S: Correlation of tensile strength with bursting pressure in the evaluation of intestinal anastomosis. Dig Surg 1999;16:478-485.
23.
Månsson P, Zhang XW, Jeppsson B, Thorlacius H: Anastomotic healing in the rat colon: comparison between a radiological method, breaking strength and bursting pressure. Int J Colorectal Dis 2002;17:420-425.
24.
De Hingh IH, Siemonsma MA, de Man BM, Lomme RM, Hendriks T: The matrix metalloproteinase inhibitor BB-94 improves the strength of intestinal anastomoses in the rat. Int J Colorectal Dis 2002;17:348-354.
25.
Hendriks T, Mastboom WJ: Healing of experimental intestinal anastomoses. Parameters for repair. Dis Colon Rectum 1990;33:891-901.
26.
Syk I, Ågren MS, Adawi D, Jeppsson B: Inhibition of matrix metalloproteinases enhances breaking strength of colonic anastomoses in an experimental model. Br J Surg 2001;88:228-234.
27.
Danielsen PL, Ågren MS, Jorgensen LN: Platelet-rich fibrin versus albumin in surgical wound repair: a randomized trial with paired design. Ann Surg 2010;251:825-831.
28.
Viljanto J, Kulonen E: Correlation of tensile strength and chemical composition in experimental granuloma. Acta Pathol Microbiol Scand 1962;56:120-126.
29.
Martens MF, Huyben CM, Hendriks T: Collagen synthesis in fibroblasts from human colon: regulatory aspects and differences with skin fibroblasts. Gut 1992;33:1664-1670.
30.
Coon KD, Inge LJ, Swetel K, Felton V, Stafford P, Bremner RM: Genomic characterization of the inflammatory response initiated by surgical intervention and the effect of perioperative cyclooxygenase 2 blockade. J Thorac Cardiovasc Surg 2010;139:1253-1260.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.